Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,781 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Dosing patterns of three tumor necrosis factor blockers among patients with rheumatoid arthritis in a large United States managed care population.
Fisher MD, Watson C, Fox KM, Chen YW, Gandra SR. Fisher MD, et al. Among authors: watson c. Curr Med Res Opin. 2013 May;29(5):561-8. doi: 10.1185/03007995.2013.786693. Epub 2013 Apr 3. Curr Med Res Opin. 2013. PMID: 23489410
Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.
Hone D, Cheng A, Watson C, Huang B, Bitman B, Huang XY, Gandra SR. Hone D, et al. Among authors: watson c. Arthritis Care Res (Hoboken). 2013 Oct;65(10):1564-72. doi: 10.1002/acr.22022. Arthritis Care Res (Hoboken). 2013. PMID: 23554320
Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.
Bonafede MM, Fox KM, Johnson BH, Watson C, Gandra SR. Bonafede MM, et al. Among authors: watson c. Clin Ther. 2012 Feb;34(2):457-67. doi: 10.1016/j.clinthera.2011.12.016. Epub 2012 Jan 28. Clin Ther. 2012. PMID: 22284901
Cost per treated patient for etanercept, adalimumab, and infliximab across adult indications: a claims analysis.
Bonafede MM, Gandra SR, Watson C, Princic N, Fox KM. Bonafede MM, et al. Among authors: watson c. Adv Ther. 2012 Mar;29(3):234-48. doi: 10.1007/s12325-012-0007-y. Epub 2012 Mar 9. Adv Ther. 2012. PMID: 22411424
Treatment patterns following discontinuation of adalimumab, etanercept, and infliximab in a US managed care sample.
Yeaw J, Watson C, Fox KM, Schabert VF, Goodman S, Gandra SR. Yeaw J, et al. Among authors: watson c. Adv Ther. 2014 Apr;31(4):410-25. doi: 10.1007/s12325-014-0110-3. Epub 2014 Mar 7. Adv Ther. 2014. PMID: 24604700
Patients were categorized into mutually exclusive groups in descending order: (a) restart of index TNF blocker; (b) switch to another TNF blocker; (c) switch to a different biologic; (d) switch to nonbiologic therapy; or (e) no new treatment. ...
Patients were categorized into mutually exclusive groups in descending order: (a) restart of index TNF blocker; (b) switch to another TNF bl …
Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population.
Schabert VF, Watson C, Joseph GJ, Iversen P, Burudpakdee C, Harrison DJ. Schabert VF, et al. Among authors: watson c. J Manag Care Pharm. 2013 Oct;19(8):621-30. doi: 10.18553/jmcp.2013.19.8.621. J Manag Care Pharm. 2013. PMID: 24074008
Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting.
Bonafede M, Johnson BH, Fox KM, Watson C, Gandra SR. Bonafede M, et al. Among authors: watson c. J Dermatolog Treat. 2013 Oct;24(5):369-73. doi: 10.3109/09546634.2012.755255. Epub 2013 May 21. J Dermatolog Treat. 2013. PMID: 23441722 Free PMC article.
Etanercept and adalimumab treatment patterns in psoriatic arthritis patients enrolled in a commercial health plan.
Chastek B, Fox KM, Watson C, Gandra SR. Chastek B, et al. Among authors: watson c. Adv Ther. 2012 Aug;29(8):691-7. doi: 10.1007/s12325-012-0039-3. Epub 2012 Aug 16. Adv Ther. 2012. PMID: 22903239
Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings.
Bonafede M, Fox KM, Watson C, Princic N, Gandra SR. Bonafede M, et al. Among authors: watson c. Adv Ther. 2012 Aug;29(8):664-74. doi: 10.1007/s12325-012-0037-5. Epub 2012 Aug 8. Adv Ther. 2012. PMID: 22886712
Psoriasis treatment patterns with etanercept and adalimumab in a United States health plan population.
Chastek B, Fox KM, Watson C, Kricorian G, Gandra SR. Chastek B, et al. Among authors: watson c. J Dermatolog Treat. 2013 Feb;24(1):25-33. doi: 10.3109/09546634.2012.661038. Epub 2012 Jun 5. J Dermatolog Treat. 2013. PMID: 22668321
2,781 results
Jump to page
Feedback